Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

DNA methylation biomarkers for noninvasive detection of triple‐negative breast cancer using liquid biopsy

28 Oct 2022

Abstract excerpt

Noninvasive detection of aberrant DNA methylation could provide invaluable biomarkers for earlier detection of triple-negative breast cancer (TNBC) which could help clinicians with easier and more efficient treatment options. We evaluated genome-wide DNA methylation data derived from TNBC and normal breast tissues, peripheral blood of TNBC cases and controls and reference samples of sorted blood and mammary...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Cells and Metastasis
Share to Cancer Genomics and Diagnostics
Share to Epigenetics and DNA Methylation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 36305646
DOI: 10.1002/ijc.34337

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

DNA methylation biomarkers for noninvasive detection of triple‐negative breast cancer using liquid biopsyPMID 36305646Read ↗

Discovery and validation of cell-free DNA methylation markers for specific diagnosis, differentiation from benign tumors, and prognosis of breast cancerSemantic proximity Read ↗

Multimodal analysis of cell-free DNA enhances differentiation of early-stage breast cancer from benign lesions and healthy individualsSemantic proximity Read ↗

A DNA methylation-based liquid biopsy for triple-negative breast cancerSemantic proximity Read ↗

Circulating cell-free DNA-based epigenetic assay can detect early breast cancerSemantic proximity Read ↗

The applications of plasma cell-free DNA in cancer detection: Implications in the management of breast cancer patients.Semantic proximity Read ↗

DNA methylation biomarkers for the diagnosis and treatment management of breast cancer: where are we now?Semantic proximity Read ↗

A DNA Methylation-Based Test for Breast Cancer Detection in Circulating Cell-Free DNASemantic proximity Read ↗

DNA Methylation-Based Testing in Liquid Biopsies as Detection and Prognostic Biomarkers for the Four Major Cancer TypesSemantic proximity Read ↗

Νovel methylation biomarkers in liquid biopsy and classifying biosignatures for the clinical management of Breast CancerSemantic proximity Read ↗

Early-Stage Breast Cancer Detection in Breast Milk.Semantic proximity Read ↗

Differential methylation of circulating free DNA assessed through cfMeDiP as a new tool for breast cancer diagnosis and detection of BRCA1/2 mutation.Semantic proximity Read ↗

Whole‐genome bisulfite sequencing analysis of circulating tumour DNA for the detection and molecular classification of cancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.